Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pamela J. Baker is active.

Publication


Featured researches published by Pamela J. Baker.


Journal of Dental Research | 1985

Antibiotic Susceptibility of Anaerobic Bacteria from the Human Oral Cavity

Pamela J. Baker; Richard T. Evans; Jorgen Slots; Robert J. Genco

Anaerobic, agar-dilution, minimal inhibitory concentrations (MICs) of 18 antibiotics are given for the numerically important bacterial groups from the human oral cavity. Strains are divided into susceptibility categories using the guidelines for interpretation of MICs suggested by the National Committee for Clinical Laboratory Standards. These guidelines are based on data on antibiotic concentrations attainable in serum following various dosage regimens. MICs are also compared with attainable gingival fluid levels where these are known. The highest percentages of strains were susceptible to tetracycline, with 89% of the 139 strains tested susceptible to serum levels and 97% conditionally susceptible to attainable gingival fluid levels. Ninety-eight percent of strains were conditionally susceptible to attainable gingival fluid levels of minocycline, but many strains, including Actinobacillus actinomycetemcomitans, were only moderately susceptible to attainable serum levels of this tetracycline analogue. Carbenicillin was effective against most groups of organisms, with the important exception of A. actinomycetemcomitans, at serum levels attainable with oral formulations of carbenicillin. Only 2% of the total strains tested were resistant to penicillin, while 33% of strains were categorized as moderately susceptible. Clindamycin was active against many strains of Gram-negative bacteria but was not active against A. actinomycetemcomitans, some Bacteroides, Eikenella corrodens, or the anaerobic vibrios. Metronidazole was active against A. actinomycetemcomitans, all five groups of oral Bacteroides tested, and against Capnocytophaga species. Chloramphenicol was active against A. actinomycetemcomitans, but not against most of the other groups of oral organisms. Nearly all groups contained strains non-susceptible to serum levels attainable with the usual doses of erythromycin, spiramycin, vancomycin, kanamycin, neomycin, streptomycin, doxycycline, oxytetracycline, or chlortetracycline; several strains were resistant to maximum attainable serum levels of each of these antibiotics except doxycycline.


Antimicrobial Agents and Chemotherapy | 1983

Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria.

Pamela J. Baker; Jørgen Slots; Robert J. Genco; Richard T. Evans

The minimal inhibitory concentrations of a series of antimicrobial agents for human oral organisms were determined under anaerobic growth conditions by an agar dilution assay. With the exception of black-pigmented Bacteroides spp., minimal inhibitory concentrations for oral isolates were similar to those for non-oral isolates of organisms of the same or closely related species.


Journal of Dental Research | 1977

Comparison of Antiplaque Agents Using an In Vitro Assay Reflecting Oral Conditions

Richard T. Evans; Pamela J. Baker; Robert A. Coburn; Robert J. Genco

An in vitro assay is described using saliva-treated bovine enamel slabs for determining the potential of chemotherapeutic agents to adsorb to tooth surfaces and act against plaque-forming bacteria. Chlorhexidine was found to inhibit the formation of in vitro plaque by Actinomyces viscosus, A naeslundii, Streptococcus mutans and S sanguis. Actinobolin was found to have marked antibacterial properties but limited adsorptive qualities.


Journal of Dental Research | 1987

Structural Determinants of Activity of Chlorhexidine and Alkyl Bisbiguanides Against the Human Oral Flora

Pamela J. Baker; Robert A. Coburn; Robert J. Genco; Richard T. Evans

We assayed chlorhexidine and a series of its analogues, in which the chlorophenyl terminal substituents were replaced with alkyl chains, for their in vitro antimicrobial activity against the Gram-negative and Gram-positive oral bacteria. Changes in antimicrobial activity were correlated with changes in agent structure for identification of structural criteria which may be important in the optimization of agent activity. Chlorhexidine showed substantial antimicrobial activity against the Gram-negative as well as the Gram-positive oral bacteria. The alkyl agents were comparable with chlorhexidine in their activity against Bacteroides gingivalis and Bacteroides intermedius, black-pigmented Gram-negative obligate anaerobes associated with periodontal disease in adults. Alkyl agents alexidine, heptihexidine (1,6-bis-n-heptylbiguanidohexane), hexoctidine (1,8-bis-n-hexylbiguanidooctane), and hexhexidine (1,6-bis-n-hexylbiguanidohexane), as well as chlorhexidine, were active against Actinobacillus actinomycetemcomitans, a Gram-negative organism associated with localized juvenile periodontitis. Hexidecidine (1,10-bis-n-hexylbiguanidodecane) and heptoctidine (1,8-bis-n-heptylbiguanidooctane) were more active, and hexhexidine was as active as chlorhexidine against Fusobacterium nucleatum, also associated with periodontal disease. Seven of the agents were more active than chlorhexidine against Actinomyces species. All test agents were active against Streptococcus mutans, a Gram- positive coccus associated with dental caries. Hexidecidine had activity equal to that of chlorhexidine when evaluated against the entire battery of organisms. Analysis of structure-activity relationships revealed that alkyl chains could replace chlorophenyl groups with retention or improvement of antimicrobial activity. Agents with lower lipophilicity were generally more active than those with higher lipophilicity. Within an isolipophilic series, activity increased as methylene bridge length increased, with a requirement for a bridge of at least six carbons for activity against most bacteria. Agents with branched terminal groups were more active than agents of the same bridge length but with unbranched terminal groups. The alkyl bisbiguanides, agents which do not contain chlorophenyl moieties, have activity against the oral flora comparable with that of chlorhexidine. Of the alkyl agents evaluated in this study, hexidecidine, hexhexidine, and alexidine offer the most promise for use in control of oral diseases.


Journal of Periodontal Research | 1986

A biochemical approach to periodontal regeneration: Tetracycline treatment of dentin promotes fibroblast adhesion and growth

Victor P. Terranova; Louis C. Franzetti; Susanne Hic; Roberta M. Diflorio; Raymond M. Lyall; Ulf M. E. Wikesjo; Pamela J. Baker; Lars A. Christersson; Robert J. Genco


Journal of Periodontal Research | 1986

A biochemical approach to periodontal regeneration: Tetracycline treatment conditions dentin surfaces

Ulf M. E. Wikesjo; Pamela J. Baker; Lars A. Christlrsson; Robert J. Genco; Raymond M. Lyall; Susanne Hic; Roberta M. Diflorio; Victor P. Terranova


Journal of Periodontology | 1983

Tetracycline and Its Derivatives Strongly Bind to and Are Released From the Tooth Surface in Active Form

Pamela J. Baker; Richard T. Evans; Robert A. Coburn; Robert J. Genco


Journal of Clinical Periodontology | 1985

Susceptibility of human oral anaerobic bacteria to antibiotics suitable for topical use

Pamela J. Baker; Richard T. Evans; Jørgen Slots; Robert J. Genco


Journal of Periodontology | 1993

Retention of Antimicrobial Activity by Human Root Surfaces after in Situ Subgingival Irrigation with Tetracycline HCl or Chlorhexidine

Ayala Stabholz; James D. Kettering; Raydolfo M. Aprecio; Grenith Zimmerman; Pamela J. Baker; Ulf M. E. Wikesjö


Journal of Periodontal Research | 1978

The in vitro inhibition of microbial growth and plaque formation by surfactant drugs.

Pamela J. Baker; Robert A. Coburn; Robert J. Genco; Richard T. Evans

Collaboration


Dive into the Pamela J. Baker's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jørgen Slots

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge